These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6225335)

  • 21. Phenotypic variation in 2 Huntington's disease families with linkage to chromosome 4.
    Sax DS; Bird ED; Gusella JF; Myers RH
    Neurology; 1989 Oct; 39(10):1332-6. PubMed ID: 2529452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigene conversion: a proposal with implications for gene mapping in humans.
    Sabl JF; Laird CD
    Am J Hum Genet; 1992 Jun; 50(6):1171-7. PubMed ID: 1534643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study.
    Li JL; Hayden MR; Warby SC; Durr A; Morrison PJ; Nance M; Ross CA; Margolis RL; Rosenblatt A; Squitieri F; Frati L; Gómez-Tortosa E; García CA; Suchowersky O; Klimek ML; Trent RJ; McCusker E; Novelletto A; Frontali M; Paulsen JS; Jones R; Ashizawa T; Lazzarini A; Wheeler VC; Prakash R; Xu G; Djoussé L; Mysore JS; Gillis T; Hakky M; Cupples LA; Saint-Hilaire MH; Cha JH; Hersch SM; Penney JB; Harrison MB; Perlman SL; Zanko A; Abramson RK; Lechich AJ; Duckett A; Marder K; Conneally PM; Gusella JF; MacDonald ME; Myers RH
    BMC Med Genet; 2006 Aug; 7():71. PubMed ID: 16914060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E and presenilin-1 genotypes in Huntington's disease.
    Panas M; Avramopoulos D; Karadima G; Petersen MB; Vassilopoulos D
    J Neurol; 1999 Jul; 246(7):574-7. PubMed ID: 10463359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA marker studies show that Machado Joseph disease is not an allele of the Huntington disease locus.
    Forse RA; MacLeod P; Holden JJ; White BN
    J Neurogenet; 1989 May; 5(2):155-8. PubMed ID: 2525613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of social selection on the population dynamics of Huntington's disease.
    Yokoyama S; Templeton A
    Ann Hum Genet; 1980 May; 43(4):413-7. PubMed ID: 6446873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease.
    Nance MA; Mathias-Hagen V; Breningstall G; Wick MJ; McGlennen RC
    Neurology; 1999 Jan; 52(2):392-4. PubMed ID: 9932964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duration of illness in Huntington's disease is not related to age at onset.
    Roos RA; Hermans J; Vegter-van der Vlis M; van Ommen GJ; Bruyn GW
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):98-100. PubMed ID: 8429330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic imprinting: a possible mechanism for the parental origin effect in Huntington's chorea.
    Reik W
    J Med Genet; 1988 Dec; 25(12):805-8. PubMed ID: 2976840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.
    Vuillaume I; Vermersch P; Destée A; Petit H; Sablonnière B
    J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):758-62. PubMed ID: 9647305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic features of Huntington's disease-like 2.
    Walker RH; Jankovic J; O'Hearn E; Margolis RL
    Mov Disord; 2003 Dec; 18(12):1527-30. PubMed ID: 14673892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and genetic data of Huntington disease in Moroccan patients.
    Bouhouche A; Regragui W; Lamghari H; Khaldi K; Birouk N; Lytim S; Bellamine S; Kriouile Y; Bouslam N; Haddou el HA; Faris MA; Benomar A; Yahyaoui M
    Afr Health Sci; 2015 Dec; 15(4):1232-8. PubMed ID: 26958025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Huntington's disease: predictive testing and the molecular genetics laboratory.
    Lazarou LP; Meredith AL; Myring JM; Tyler A; Morris M; Ball DM; Harper PS
    Clin Genet; 1993 Mar; 43(3):150-6. PubMed ID: 8098998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive testing in the context of pregnancy: experience in Huntington's disease and autosomal dominant cerebellar ataxia.
    Lesca G; Goizet C; Dürr A
    J Med Genet; 2002 Jul; 39(7):522-5. PubMed ID: 12114488
    [No Abstract]   [Full Text] [Related]  

  • 35. Huntington's disease in two New Britain families.
    Scrimgeour EM
    J Med Genet; 1980 Jun; 17(3):197-202. PubMed ID: 6447211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular diagnosis of Huntington disease in Brazilian patients.
    Lima E Silva TC; Serra HG; Bertuzzo CS; Lopes-Cendes I
    Arq Neuropsiquiatr; 2000 Mar; 58(1):11-7. PubMed ID: 10770860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature.
    Gonzalez-Alegre P; Afifi AK
    J Child Neurol; 2006 Mar; 21(3):223-9. PubMed ID: 16901424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping of the DNA locus D4S10 and the linked Huntington's disease gene to 4p16----p15.
    Zabel BU; Naylor SL; Sakaguchi AY; Gusella JF
    Cytogenet Cell Genet; 1986; 42(4):187-90. PubMed ID: 2944714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course.
    Squitieri F; Gellera C; Cannella M; Mariotti C; Cislaghi G; Rubinsztein DC; Almqvist EW; Turner D; Bachoud-Lévi AC; Simpson SA; Delatycki M; Maglione V; Hayden MR; Donato SD
    Brain; 2003 Apr; 126(Pt 4):946-55. PubMed ID: 12615650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Considerations in using linkage analysis as a presymptomatic test for Huntington's disease.
    Farrer LA; Myers RH; Cupples LA; Conneally PM
    J Med Genet; 1988 Sep; 25(9):577-88. PubMed ID: 2903248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.